Site Map Press Room Careers
Financial
Quarterly Results
Financial Highlights
Annual Reports
Business Drivers
Investors
Share Performance
Contact Person
Frequently Asked Questions
 Quarterly Results
Audited Quarterly Results for the Year ended 31st March, 2002
  (Rs.in Mio)
Particulars Name of the shareholder Number of shares Shares as a percentage of total number of shares ( I.e. Grand Total (A)+(B)+(C) indicated in statement at para (I)(a) above
  31-12-2001 31-03-2002 31-03-2001 31-03-2002 31-03-2001
  (Unaudited) (Unaudited) (Unaudited) (Audited) (Audited)
Net Sales/Income from Operations 7186.7 3190.5 2467.5 10377.2 9961.0
Other Income 119.5 27.3 68.6 146.8 116.5
Total income 7306.2 3217.8 2536.1 10524.0 10077.5
Expenditure          
a. (Increase)/Decrease in Stock in Trade 30.8 178.5 (33.9) 209.3 (472.4)
b. Consumption of Raw Material 4662.1 2009.6 1591.2 6671.7 6968.4
c. Staff Cost 181.8 69.9 83.6 251.7 216.2
d. Other Expenditure 1440.6 580.3 668.9 2020.9 1966.4
Total expenditure 6315.3 2838.3 2309.8 9153.6 8678.6
Profit before depreciation, interest & tax 990.9 379.5 226.3 1370.4 1398.9
Interest 314.5 109.4 175.9 423.9 416.8
Depreciation 118.3 39.8 48.2 158.1 147.8
Profit before extra-ordinary item & taxation 558.1 230.3 2.2 788.4 834.3
Add: Extra-ordinary item (refer note 4) 0.0 100.0 0.0 100.0 0.0
Profit after extra ordinary item & before taxation 558.1 330.3 2.2 888.4 834.3
Provision for Taxation          
a. Current Tax 87.0 66.7 15.9 153.7 150.9
b. Deferred Tax 12.0 25.9 0.0 37.9 0.0
c. Tax adjustments of previous years   11.7 0.3 11.7 0.3
Net Profit 459.1 226.0 (14.0) 685.1 683.1
Paid-up Equity Share Capital 202.0 206.7 202.0 206.7 202.0
(Face value Rs. 10 per share)          
Reserves excluding Revaluation Reserve       3406.9 2564.1
Basic Earnings per share (Rs.) (not annualised) 22.73 11.66 (0.69) 33.89 33.82
Diluted Earnings per share (Rs.) 22.73 11.66 (0.69) 33.89 33.82
Aggregate of non-promoters Shareholding          
a. Number of Shares 6,856,864     6,978,167 7,376,960
b. Percentage of Shareholding 33.94     33.76 36.88
 
Segmentwise Revenue Results and Capital Employed Under Clause 41 of the Listing Agreement
 
Particulars Nine months ended Quarter ended Year ended
1. Segment Revenue      
a .  Bulk Drugs & Drug Intermediaries 6781.4 4074.5 10855.9
b.  Formulation 650.5 411.2 1061.7
c.  Research & Development 0.0 0.0 0.0
Total 7431.9 4485.7 11917.6
Less: Inter segment revenue -239.7 -1193.3 -1433.0
Net Sales/Income from operation 7192.2 3292.4 10484.6
2. Segment Results Profit(+) / Loss(-) before tax and interest      
a .  Bulk Drugs & Drug Intermediaries 870.8 573.8 1444.6
b.  Formulation 16.3 211.5 227.8
c.  Research & Development -49.1 -11.4 -60.5
Total 838.0 773.9 1611.9
Less:  (I) Interest (Net) 292.4 100.1 392.5
(ii) Other un-allocable -12.5 343.4 330.9
expenditure net of      
unallocable income      
Total Profit before tax 558.1 330.4 888.5
3. Capital Employed      
a .  Bulk Drugs 5343.1 3870.9 3870.9
b.  Formulation 646.2 1180.0 1180.0
c.  Research & Development 176.2 173.9 173.9
Total 6165.5 5224.8 5224.8
Notes:
1.

The above audited results have been taken on record by the Board of Directors at its meeting held on 30.06.2002.
2.

In terms of Accounting Standard - 17, the revenue, results and capital employed have ben given segment wise.
3.

The Company allotted 4,70,000 equity shares of Rs.10/- each at a premium of Rs.216/- and equal number of share warrants by way of preferential issue on private placement basis during the year.
4.

The extra-ordinary item represents income from sale of brands to a JV.
5.

Directors recommend a dividend of Rs.3.00 per each share subject to approval of shareholders.
6.

The qualification in the Auditors' Report pertaining to non inclusion of non-compete fee of Rs.300 millions in the P&L Account, it is being a capital receipt, the Company has directly taken into capital reserves in the Balance Sheet.
7.

The figures of the previous periods have been re-grouped, wherever necessary.
    For and on behalf of the Board
Place: Hyderabad    K.Nityananda Reddy
Date : 30.06.2002   Managing Director
Site Map Press Room Careers